EDSA · Annual Report (Form 10-K) · Filed December 12, 2025

Edesa Biotech Inc — 10-K exhibit

ex_897844.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in Registration Statement Nos. 333-217480, 333-236121, 333-255485, 333-272176, 333-279887 and 333-287618 on Form S-8, Registration Statement Nos. 333-233567, 333-266604, 333-268847, 333-285539 and 333-288966 on Form S-3 and Registration Statement No. 333-264235 on Form S-1 of our auditor’s report dated December 12, 2025 with respect to the consolidated ﬁnancial statements of Edesa Biotech, Inc. as at September 30, 2025 and 2024 and for each of the years in the two year period ended September 30, 2025, as included in the Annual Report on Form 10-K of Edesa Biotech, Inc. for the year ended September 30, 2025 as ﬁled with the United States Securities and Exchange Commission.

/s/ MNP LLP

Chartered Professional Accountants

Licensed Public Accountants

Toronto, Canada

December 12, 2025

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer